The aim of the present study was to investigate the antimicrobial and cytotoxic activities of five newly synthesized ferrocene based complexes [Mn {Fcd (COO) . Brine shrimp bioassay lethality was carried out for cytotoxicity measurements of the complexes and the LC 50 values were calculated after probit transformation of the resulting mortality data. Among the five complexes manganese complex A was showed highest cytotoxic effect, which is indicative of its probable effect on cancer cell lines.
INTRODUCTION
Cancer is caused when genetic damage to the cells prevents them being responsible to normal tissue controls. The cancer spreads when affected cells multiply rapidly, forming tumors of varying degrees. Different therapies can be used, depending on how far the cancer has spread. Anticancer drugs have originated from a variety of sources, including dyestuffs and chemical warfare agents, and from natural products such as plants, microbes and fungi. One of the most potent and effective antitumor agents was discovered in the last century . Transition metal co-ordination complexes have now been widely studied for their antimicrobial and anticancer properties (Beur et al., 1966; Amirkhanov et al., 1999; Biswas et al., 2002) . Cisplatin is one of the most potent and effective antitumor agents but it lacks selectivity for tumor tissue and many tumors are growing resistance to this platinum complex (Brachia et al., 1999; Britten et al., 2005) . To address this problem modified versions of cisplatin, leading to second and third generation platinum-based drugs have been synthesized over the past 30 years and have got their less toxic effect to the host tissue (Chaudhary et al., 2003) . The scientists are now engaged to explore other transition based complexes and other complexes (Finncy, 1971; Kelland et al., 1994; Friedrich et al., 1998; Dentine-Samara et al., 2002; Islam et al., 2002; Joudah et al., 2002; Kamalakannan & Venkappayya, 2002; Hossain et al., 2004) . In the continuation of this discovery present studies synthesized five new ferrocene-derivative metal complexes and have studied their cytotoxicity, antibacterial and antifungal activities.
MATERIALS AND METHODS
Methods. All chemicals used were of reagent grade. Solvents were distilled and dried before use according to standard procedures. The metal complexes were prepared by the literature methods. The metal salts used were generally in their hydrated form.
Preparation of [Mn {Fcd (COO) 2 }
, A]. The 5 mL aqueous solution of Fcd (COONa) 2 0.0319 g (0.1 mm) was dropped slowly into the 4 ml CH 3 OH solution of MnCl 2 .4H 2 O 0.0198 g (0.1 mm) contained in a 50 mL round bottom flask, the mixture was stirred and then was put in the dark. About 10 days later, the orange crystals were obtained. Then it was filtered and washed with methanol (CH 3 OH) and dried under vacuum. The product was free from starting materials (Checked by TLC). Yield: 0.0297 g, 91%. Melting point: > 300°C (decomp). Preparation of [Co {Fcd(COO) 2 }, B]. The 5 mL aqueous solution of Fcd (COONa) 2 0.0319 g (0.1 mm) was dropped slowly into the 4 mL CH 3 OH solution of (CH 3 COO) 2 Co. 4H 2 O 0.0249 g (0.1 mm) contained in a 50 mL round bottom flask, the mixture was stirred and then was put in the dark. About 10 days later, the yellow crystals were obtained. Then it was filtered and washed with methanol (CH 3 OH) and dried under vacuum. The product was free from starting materials (Checked by TLC). Yield: 0.0275 g, 83%. Melting point: > 300°C (decomp). Preparation of [Ni {Fcd (COO) 2 }, C]. The 5 mL aqueous solution of Fcd (COONa) 2 0.0319 g (0.1 mm) was dropped slowly into the 6 mL CH 3 OH solution of (CH 3 COO) 2 Ni. 4H 2 O 0.0248 g (0.1 mm) contained in a 50 mL round bottom flask, the mixture was stirred and then was put in the dark. About 10 days later, the yellow crystals were obtained. Then it was filtered and washed with methanol (CH 3 OH) and dried under vacuum. The product was free from starting materials (Checked by TLC). Yield: 0.0261 g, 79%. Melting point: > 300°C (decomp). Preparation of [Cu {Fcd (COO) 2 }, D]. The 5 mL aqueous solution of Fcd (COONa) 2 0.0319 g (0.1 mm) was dropped slowly into the 5 mL CH 3 OH solution of (CH 3 COO) 2 Cu. H 2 O 0.0171 g (0.1 mm) contained in a 50 mL round bottom flask, the mixture was stirred and then was put in the dark. About 10 days later, the gray crystals were obtained. Then it was filtered and washed with methanol (CH 3 OH) and dried under vacuum. The product was free from starting materials (Checked by TLC). Yield: 0.0251 g, 75%. Melting point: > 300°C (decomp). Preparation of [Zn {Fcd (COO) 2 }, E]. The 5 mL aqueous solution of Fcd (COONa) 2 0.0319 g (0.1 mm) was dropped slowly into the 5 mL CH 3 OH solution of (CH 3 COO) 2 Zn 2H 2 O 0.0199 g (0.1 mm) contained in a 50 mL round bottom flask, the mixture was stirred and then was put in the dark. About 10 days later, the reddish yellow crystals were obtained. Then it was filtered and washed with methanol (CH 3 OH) and dried under vacuum. The product was free from starting materials (Checked by TLC). Yield: 0.0259 g, 77%. Melting point: > 300°C (decomp). Antibacterial screening. In vitro antibacterial screening is generally performed by disc diffusion methods for the primary selection of compounds as therapeutic agents (Mayer et al., 1982; Kurbacher et al., 1994) . In this method activity of the test compounds are expressed by measuring the diameter of zone of inhibition. Generally, the more susceptible the organisms the bigger the zone of inhibition. The method essentially a qualitative or semi quantitative test indicating sensitivity or resistance of microorganisms to the test material as well as bacteriostetic or bactericidal activity of a compound (Kurbacher et al., 1994 (Mellor et al., 2005) . The results were compared with the standard antibiotic kanamycin. The media used in this respect was nutrient broth (DIFCO). Antifungal assay. The antifungal activities of the complexes were tested against four pathogenic fungi (Candida albicans, Aspergillus niger, Aspergillus fumigatus & aaspergillus flavus) at a concentration of 50 and 200 μG disc -1 for each. The media used in this respect was potato dextrose agar (PDA). The activity was determined after 72 h of incubation at room temperature. For a better correlation of the anti fungal activities Fluconazole 50 μG disc -1 was used as a standard. Cytotoxicity bioassay. Brine shrimp lethality bioassay is a recent development in the assay procedure of bioactive compound, which indicates cytotoxicity as well as a wide range of pharmacological activities (such as anticancer, antiviral, insecticidal, pesticidal, AIDS etc) of the compounds (Mishra et al., 1995) . Here in vivo lethality test was carried out by using brine shrimp nauplii eggs (Artemia salina L.). Eggs were hatching 48 h in 3.8% NaCl solution (Sea water) and after two days of hatching, the nauplii were ready for experiment as described previously (Quievryn et al., 2003) . Standard solutions of the complexes were prepared whose concentration was 5μG mL -1 (3 mg of each complex was dissolved in 0.6 mL of Dimethyl Sulfoxide). From the stock solution 5, 10, 20, 40 and 80 μL were placed in 5 different vials and the volume was made up to 5 mL with NaCl (3.8%) solution. Thus the final concentration of the sample in the vials became 5, 10, 20, 40 and 80 μM mL -1 , respectively. Then 10 brine shrimp nauplii were placed in each vial. For the control of each vial, one vial containing equal volume of Dimethyl Sulfoxide (DMSO) and NaCl solution up to 5 mL. After 24 h of incubation, each vial was observed using a magnifying glass and the number of survivors in each vial was counted and noted. From the data % of mortality was calculated and plotted against Log dose (log C). From the graph LC 50 values of the complexes were determined using probit analysis (Reiner et al., 1982) .
RESULTS AND DISCUSSION
Antibacterial activity. The metal complex A show moderate antibacterial activities at the concentration of 30 μG/disc with respect to the standard antibiotic Kanamycin but showed remarkable activities at the high concentration of 100 μG disc -1 against both gram positive and gram negative bacteria. The reports listed in Table I show that the other metal complexes (B-E) did not show remarkable activities at the concentration of 30 μG disc -1 but show moderate activity at the concentration of 100 μG disc -1 . The more antibacterial activity of the complex A may be due to the metal manganese. Further studies were needed to explore the mechanism of antibacterial activity of these ferrocene derivative compounds. Manganese complexes have been reported for their antibacterial activity (Rosenberg et al., 1965; Rios et al., 1988; Saglam et al., 2002) . Many authors also reported antibacterial activity of other transition metal complexes and our present findings supported the previous results of antibacterial activity for both manganese and other metal coordination complexes (Schabel et al., 1979; Shrivastav et al., 2002; Sultana et al., 2003) . Table II show that the MIC value of the complex A against B. subtilis, S. aureus, S. typhi and S. dysenteriae were 16, 16, 16 and 32 μG mL -1 , respectively; for the complex B, 128, 128, 128, 128, respectively and for other three complexes C, D and E no remarkable MIC values can be found. From the MIC values it was found that the ferrocene coordination complex A was more potent than the other complexes B, C, D and E.
Minimum inhibitory concentration (MIC). The reports listed in
From the MIC values it was found that the ferrocene coordination complex A was more potent than the other complexes B, C, D and E. Earlier three coordination complexes of metals with mixed ligands [Mn (ED) (2-aminophenol), A], [Fe (ED)(2-aminobenzoic acid), B] and [Fe (ED) (2-aminophenol), C] were tested for their antimicrobial activity by disc diffusion and serial dilution methods (Zakaria et al., 2000) . The minimum inhibitory concentration of the complex A was determined against four pathogenic bacteria B. subtilis, S.-β-haemolyticus, E. coli and S. typhi. The manganese complex A also showed potent cytotoxic effect, which is indicative of its probable effect on cancer cell lines. Antifungal activity. The antifungal activities of the metal complexes (A-E) and standard Fluconazole (F-50 μG disc -1 ) were determined at the concentration of 200 μG disc -1 against four pathogenic fungi are listed in Table III . It was found that the metal complex A was shown greater activity than others against all of the pathogenic fungi. The metal complex B was shown moderate activity.
The antifungal activity of other transition metal complexes also reported by many authors (Friedrich et al., 1998; Hossain et al., 2004) . Our present findings supported the previous results. Cytotoxic activity. In the brine shrimp lethality bioassay the synthetic complexes (A -E) showed positive results indicating that the complexes are biologically active. The mortality rate of brine shrimp nauplii was found to increase with the increase of concentration of the sample. The reports listed in Table IV show that the LC 50 values of the complexes A, B, C, D and E are 5.85, 9.13, 25.10, 21.20 and 31 .75 ppm, respectively. The standard anticancer drug gave its LC 50 value at 0.41 ppm. The lowest LC 50 value was found in case of complex A (5.85 ppm) followed by B (9.13 ppm), which is indicative of its higher cytotoxicity and anticancer effect on cancer cell lines. Many authors explored the cytotoxic properties of ferrocene derivatives compounds and found higher activities in case of manganese complexes (Zakaria et al., 2000; Zakaria et al., 2001; Vijayalakshmi et al., 2002) . Our present results suggested the cytotoxicity of previously reported ferrocene based complexes.
Finally, we may say that, among the five complexes the tested manganese complexes A has strong cytotoxic activity but this investigation is a primary one and farther tests are required to investigate its actual mechanism of cytotoxicity and its probable effects on higher animal model and on cancer cell line. Then we may be explored it as potent cytotoxic agents with the hope of adding arsenal of weapons used against the fatal disease cancer.
